Plain-English translation of NCT06158607 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a specialized HIV prevention program works better when it's built right into addiction treatment clinics. The program combines counseling sessions with PrEP, a daily medication that can prevent HIV infection. The study wants to see if offering this medication and support directly in addiction clinics helps women take it consistently and stay protected.
Women struggling with substance use and unstable housing often face higher risks of HIV but may have trouble accessing HIV prevention services. This trial exists to see if offering this medication and support in the same place where women are already getting addiction treatment makes it easier for them to use HIV prevention and stick with it long-term.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would receive your regular addiction treatment at the clinic, plus four counseling sessions focused on HIV prevention and taking medication consistently. A nurse practitioner would prescribe the medication for you right there in the addiction clinic, and a prevention navigator would help you access resources and stay on track. The study compares this integrated approach with standard addiction treatment alone to see which helps women better protect themselves against HIV.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
United States